FDA recall D-0015-2021

PAI Holdings, LLC. dba Pharmaceutical Associates Inc · Class III · drug

Product

Citalopram Oral Solution, USP 20 mg/10 mL, 10 mL unit dose cups, Rx Only, Mfg for: Pharmaceutical Associates, Inc. Greenville, SC 29605 NDC 0121-1696-40

Reason for recall

Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint

Distribution

Nationwide.

Key facts

Status
Terminated
Initiation date
2020-09-09
Report date
2020-10-14
Termination date
2022-02-22
Voluntary/Mandated
Voluntary: Firm initiated
Location
Greenville, SC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0015-2021